NCT06892119View on ClinicalTrials.gov

Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
LymphomaMyeloma
Interventions
DRUG

Celrixafor

Use a reduced-dose of generic plerixafor

Trial Locations (1)

64460

Universidad Autónoma de Nuevo León, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT06892119 - Generic Plerixafor Efficacy of Autologous Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter